August 17, 2016 — Corindus Vascular Robotics Inc. and Acist Medical Systems Inc. are providing Fairview Southdale Hospital, Edina, Minn., with three technologies that improve workflow in the cardiac cath lab. This includes the CorPath System from Corindus, and Acist’s RXi and CVi technologies.
"I am excited to work with both companies to bring innovative solutions to the cath lab that enhance patient care," said Gregory Helmer, M.D., FACC, co-director of medical research, Fairview Southdale Hospital. "Rapid FFR and robotic PCI are significant contributions to PCI procedures and may improve safety, lesion assessment, and bring further precision to our interventional procedures."
The CorPath System is the first U.S. Food and Drug Administration (FDA)-cleared robotic-assisted system for percutaneous coronary intervention (PCI), offering robotic precision that may improve clinical outcomes and protection for physicians and staff from serious occupational hazards in the cath lab. The Acist RXi technology provides the reassurance of accurate and reliable fractional flow reserve (FFR) measurements and the advantages of Rapid Exchange technology. Acist CVi simplifies contrast injection for procedures while enhancing safety, efficiency, control and image quality.
For more information: www.corindus.com, www.acist.com
November 14, 2025 
